Phenotype Phebruary 2023 - Week 2 - Debate - Chart review gold standard validation vs innovative methods like PheValuator

[Gowtham_Rao]

Calling this groups attention to a recent post by @Christopher_Mecoli

@Christopher_Mecoli

When run against our own Hopkins Myositis Database, this resulted in N=794, which is a very good approximation (we have about 820 adult DM patients enrolled per gold standard chart review).